Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the bioengineered protein drugs market?

The market for bioengineered protein drugs has seen a significant increase in size over recent years. It’s projected to expand from $406.39 billion in 2024 to $439.29 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 8.1%. Factors contributing to this growth during the historic period include enhanced disease comprehension, regulatory authorizations, a growing incidence of chronic ailments, collaboration and partnerships, and overall market growth.

What will be the bioengineered protein drugs market size in the future?

In the near future, the market size for bioengineered protein drugs is predicted to witness a substantial surge. The market is projected to rise to a remarkable total of “$604.42 billion by 2029, with a compound annual growth rate (CAGR) of 8.3%. The notable upward trend during the predicted period is a result of several factors including the trend of personalized medicine, broadening therapeutic applications, emerging markets, a concentrated focus on rare diseases and the development of healthcare infrastructure. Key trends subtly influencing this imputed growth within the stipulated period are advancements in protein engineering, an amplified focus on monoclonal antibodies, personalized medicine and targeted therapies, the advent of next-generation biologics, and improvements in the manufacturing process.

Get your bioengineered protein drugs market report here!

https://www.thebusinessresearchcompany.com/report/bioengineered-protein-drugs-global-market-report

What main drivers are fueling expansion in the bioengineered protein drugs market?

The escalating occurrence of persistent illnesses is predicted to drive the expansion of the bioengineered protein drug market. These are the diseases that persist for over a year, requiring ongoing medical attention and limit routine physical activities. Bioengineered protein drugs offer targeted protein treatment options for chronic diseases, with applications spanning oncology and regenerative medicine utilizing combinatorial and logical strategies. For example, the World Health Organization’s 2022 Highlights disclosed in September 2022 that there were 41 million deaths around the world, with 74% of them being attributable to noncommunicable or chronic diseases, resulting in 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths due to diabetes. Hence, the growing prevalence of chronic diseases is propelling the demand for bioengineered protein drugs.

What key areas define the segmentation of the global bioengineered protein drugs market?

The bioengineered protein drugs market covered in this report is segmented –

1) By Drug Type: Recombinant Protein, Vaccine, Peptide Antibiotics, Therapeutic Enzymes, Other Drug Type

2) By Technology: Bioreactors, Fractionation, Genetically Modified Organisms, Genetic Engineering, Pharming, Cell Culture, Microbial Cell Fermentation, Other Technology

3) By Application: Autoimmune, Heart, Congenital, Infectious Diseases, Cancer, Diabetes, Arthritis, Other Application

4) By End User: Pharmaceutical, Contract Research Organizations, Research Institutes, Biotechnology Companies

Subsegments:

1) By Recombinant Protein: Monoclonal Antibodies, Hormones, Cytokines

2) By Vaccine: Recombinant Vaccines, DNA Vaccines

3) By Peptide Antibiotics: Lipopeptide Antibiotics, Glycopeptide Antibiotics

4) By Therapeutic Enzymes: Enzyme Replacement Therapies, Biosimilar Enzymes

5) By Other Drug Type: Fusion Proteins, Antibody-Drug Conjugates (ADCs)

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10180&type=smp

Who are the dominant players expanding their reach in the bioengineered protein drugs market?

Major companies operating in the bioengineered protein drugs market include Abbvie Inc., Amgen Inc., Astrazeneca PLC, Bayer HealthCare Pharmaceuticals LLC, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Novo Nordisk A/S, Sanofi S.A., Grifols S.A., Adma Biologics Inc., CSL Limited, Abbott Laboratories, Baxter International Inc., Fresenius Kabi AG, Merck & Co. Inc., Pfizer Inc., Biogen Inc., Bristol-Myers Squibb Company, Genentech Inc., Lonza Group AG, MedImmune LLC, Regeneron Pharmaceuticals Inc., Shire plc., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Shanghai United Cell Biotechnology Co. Ltd., Panacea Biotec Ltd.

How are evolving market trends shaping bioengineered protein drugs Strategies?

Leading firms in the bioengineered protein drug market are turning towards strategic partnerships as a means to offer necessary bioengineered protein drugs to commercial entities and governmental bodies. Strategic partnerships involve collaboration between companies, utilizing one another’s strengths and resources for shared gain and success. One such example of this occurred in June 2023, when Future Fields, a biotechnology enterprise based in Canada, joined forces with Jenthera Therapeutics, another Canada-based biotech firm focusing on devising innovative therapies for rare and complicated diseases. Through this alliance, their aim is to create an innovative cancer-combating protein using the EntoEngine platform from Future Fields, enabling cost-effective and sustainable large-scale production.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10180

Which regions are emerging as leaders in the bioengineered protein drugs market?

North America was the largest region in the bioengineered protein drugs market in 2024. The regions covered in the bioengineered protein drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Application Security Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/application-security-global-market-report

Cloud Security Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/cloud-security-global-market-report

Managed Security Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/managed-security-services-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: